{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:12:23Z","timestamp":1773796343250,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Key Laboratory of Embryo Original Diseases","award":["Shelab202305"],"award-info":[{"award-number":["Shelab202305"]}]},{"name":"Shanghai Key Laboratory of Embryo Original Diseases","award":["Shelab2022ZD01"],"award-info":[{"award-number":["Shelab2022ZD01"]}]},{"name":"Medical Science and Technology Talents Support Project of IPMCH","award":["Honghu Plan-HHJH2409"],"award-info":[{"award-number":["Honghu Plan-HHJH2409"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271664"],"award-info":[{"award-number":["82271664"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Clinical Research Center for Cell Therapy","award":["23J41900100"],"award-info":[{"award-number":["23J41900100"]}]},{"name":"Research Projects of Shanghai Municipal Council for Science and Technology","award":["20JC1412100"],"award-info":[{"award-number":["20JC1412100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Premature ovarian insufficiency (POI) is a clinically challenging condition characterized by amenorrhea and infertility in women less than 40 years of age. Although both human amniotic epithelial cells (hAECs) and human umbilical cord mesenchymal stem cells (hUC-MSCs) have shown promise in treating POI, their comparative therapeutic efficacy and mechanisms remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>hAECs and hUC-MSCs were isolated from human amniotic membrane and umbilical cords, respectively, and characterized using standard protocols. A chemotherapy-induced POI mouse model was established to evaluate follicular development, ovarian fibrosis, and fertility recovery after hAEC and hUC-MSC transplantation. Longitudinal in vivo bioluminescence imaging was used to track and compare the biodistribution and retention rates of the transplanted cells. RNA sequencing and in vitro functional assays under oxidative stress and apoptosis-induced conditions were employed to analyze the differential stress responses of hAECs and hUC-MSCs. Furthermore, cytokine arrays were utilized to profile their secretomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the chemotherapy-induced POI mouse model, both hAECs and hUC-MSCs transplantation improved ovarian function, as evidenced by increased ovarian weight, restored estrous cycle, elevated follicle counts, reduced fibrosis, and enhanced fertility. In vivo imaging revealed that both cell types primarily homed to the lungs, liver, and spleen post-transplantation, with signal intensity declining over time. Quantitative analysis revealed significantly longer in vivo retention of hAECs compare to hUC-MSCs. RNA sequencing and in vitro assays confirmed the superior antioxidant capacity of hAECs under stress conditions. Cytokine profiling showed that hAEC-CM was enriched in pro-angiogenic factors, while hUC-MSC-CM contained higher levels of immunoregulatory cytokines, a functional difference further validated by in vitro experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrate that both hAECs and hUC-MSCs are effective in restoring ovarian function and fertility in a chemotherapy-induced POI mouse model. However, these two cell types exhibit distinct therapeutic advantages attributable to their differential metabolic kinetics and paracrine profiles. Specifically, hAECs displayed prolonged in vivo retention rates compared to hUC-MSCs, consistent with their enhanced antioxidant capabilities. In terms of secretory function, hAECs demonstrated superior pro-angiogenic activity, while hUC-MSCs exhibited stronger immunomodulatory effects. These distinct properties provide critical insights for cell-type-specific selection in developing targeted therapies for ovarian dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-025-04881-7","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T06:55:23Z","timestamp":1767164123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative evaluation of the therapeutic efficacy between human amniotic epithelial cells and human umbilical cord mesenchymal stem cells in premature ovarian insufficiency"],"prefix":"10.1186","volume":"17","author":[{"given":"Qinyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuwan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"issue":"2","key":"4881_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13697137.2022.2153033","volume":"26","author":"M Li","year":"2023","unstructured":"Li M, Zhu Y, Wei J, Chen L, Chen S, Lai D. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis. Climacteric. 2023;26(2):95\u2013102.","journal-title":"Climacteric"},{"issue":"2","key":"4881_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.fertnstert.2024.11.007","volume":"123","author":"AC Eshre","year":"2025","unstructured":"Eshre AC, IMSGGo POI, Panay N, Anderson RA, Bennie A, Cedars M, Davies M, Ee C, Gravholt CH, Kalantaridou S, et al. Evidence-based guideline: premature ovarian insufficiency. Fertil Steril. 2025;123(2):221\u201336.","journal-title":"Fertil Steril"},{"key":"4881_CR3","doi-asserted-by":"publisher","first-page":"572388","DOI":"10.3389\/fendo.2020.572388","volume":"11","author":"D Mauri","year":"2020","unstructured":"Mauri D, Gazouli I, Zarkavelis G, Papadaki A, Mavroeidis L, Gkoura S, Ntellas P, Amylidi AL, Tsali L, Kampletsas E. Chemotherapy associated ovarian failure. Front Endocrinol (Lausanne). 2020;11:572388.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"4881_CR4","doi-asserted-by":"publisher","first-page":"e0144245","DOI":"10.1371\/journal.pone.0144245","volume":"10","author":"EM Chang","year":"2015","unstructured":"Chang EM, Lim E, Yoon S, Jeong K, Bae S, Lee DR, Yoon TK, Choi Y, Lee WS. Cisplatin induces overactivation of the dormant primordial follicle through PTEN\/AKT\/FOXO3a pathway which leads to loss of ovarian reserve in mice. PLoS ONE. 2015;10(12):e0144245.","journal-title":"PLoS ONE"},{"issue":"5","key":"4881_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/humupd\/dmae020","volume":"30","author":"Y Guo","year":"2024","unstructured":"Guo Y, Xue L, Tang W, Xiong J, Chen D, Dai Y, Wu C, Wei S, Dai J, Wu M, et al. Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage. Hum Reprod Update. 2024;30(5):614\u201347.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"4881_CR6","doi-asserted-by":"publisher","first-page":"R177","DOI":"10.1530\/EJE-20-1178","volume":"184","author":"J Xiong","year":"2021","unstructured":"Xiong J, Xue L, Li Y, Tang W, Chen D, Zhang J, Dai J, Zhou S, Lu Z, Wu M, et al. THERAPY OF ENDOCRINE DISEASE: novel protection and treatment strategies for chemotherapy-associated ovarian damage. Eur J Endocrinol. 2021;184(5):R177\u201392.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"4881_CR7","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.3390\/ijms23052850","volume":"23","author":"M Mousaei Ghasroldasht","year":"2022","unstructured":"Mousaei Ghasroldasht M, Seok J, Park HS, Liakath Ali FB, Al-Hendy A. Stem cell therapy: from Idea to clinical practice. Int J Mol Sci 2022, 23(5):2850.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4881_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13048-024-01492-3","volume":"17","author":"X Cui","year":"2024","unstructured":"Cui X, Jing X. Stem cell-based therapeutic potential in female ovarian aging and infertility. J Ovarian Res. 2024;17(1):171.","journal-title":"J Ovarian Res"},{"issue":"2","key":"4881_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/biom14020242","volume":"14","author":"HK Kim","year":"2024","unstructured":"Kim HK, Kim TJ. Current status and future prospects of stem cell therapy for infertile patients with premature ovarian insufficiency. Biomolecules 2024, 14(2):242.","journal-title":"Biomolecules"},{"issue":"1","key":"4881_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/genes12010006","volume":"12","author":"P Torre","year":"2020","unstructured":"Torre P, Flores AI. Current status and future prospects of perinatal stem cells. Genes (Basel) 2020, 12(1):6.","journal-title":"Genes (Basel)"},{"issue":"1","key":"4881_CR11","first-page":"28","volume":"56","author":"H Ranjbaran","year":"2018","unstructured":"Ranjbaran H, Abediankenari S, Mohammadi M, Jafari N, Khalilian A, Rahmani Z, Momeninezhad Amiri M, Ebrahimi P. Wharton\u2019s jelly derived-mesenchymal stem cells: isolation and characterization. Acta Med Iran. 2018;56(1):28\u201333.","journal-title":"Acta Med Iran"},{"issue":"20","key":"4881_CR12","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.3390\/ijms21207730","volume":"21","author":"C Qiu","year":"2020","unstructured":"Qiu C, Ge Z, Cui W, Yu L, Li J. Human amniotic epithelial stem cells: A promising seed cell for clinical applications. Int J Mol Sci 2020, 21(20):7730.","journal-title":"Int J Mol Sci"},{"key":"4881_CR13","doi-asserted-by":"publisher","first-page":"1466529","DOI":"10.3389\/fimmu.2024.1466529","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, Lu Y, Zhao J, Luo Y, Hao W, Zhang W, He Z. Reinvesting the cellular properties of human amniotic epithelial cells and their therapeutic innovations. Front Immunol. 2024;15:1466529.","journal-title":"Front Immunol"},{"issue":"3","key":"4881_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12015-022-10493-y","volume":"19","author":"A Umer","year":"2023","unstructured":"Umer A, Khan N, Greene DL, Habiba UE, Shamim S, Khayam AU. The therapeutic potential of human umbilical cord derived mesenchymal stem cells for the treatment of premature ovarian failure. Stem Cell Rev Rep. 2023;19(3):651\u201366.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"4881_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s13287-021-02529-w","volume":"12","author":"O Shareghi-Oskoue","year":"2021","unstructured":"Shareghi-Oskoue O, Aghebati-Maleki L, Yousefi M. Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure. Stem Cell Res Ther. 2021;12(1):454.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"4881_CR16","doi-asserted-by":"publisher","first-page":"e12938","DOI":"10.1111\/cpr.12938","volume":"53","author":"L Yan","year":"2020","unstructured":"Yan L, Wu Y, Li L, Wu J, Zhao F, Gao Z, Liu W, Li T, Fan Y, Hao J, et al. Clinical analysis of human umbilical cord mesenchymal stem cell allotransplantation in patients with premature ovarian insufficiency. Cell Prolif. 2020;53(12):e12938.","journal-title":"Cell Prolif"},{"issue":"1","key":"4881_CR17","doi-asserted-by":"publisher","first-page":"2382818","DOI":"10.1080\/09513590.2024.2382818","volume":"40","author":"X Zhao","year":"2024","unstructured":"Zhao X, Yu Z, Wang X, Li X, Liu Y, Wang L. The administration of human amniotic epithelial cells in premature ovarian insufficiency: from preclinical to clinical. Gynecol Endocrinol. 2024;40(1):2382818.","journal-title":"Gynecol Endocrinol"},{"key":"4881_CR18","doi-asserted-by":"publisher","first-page":"102744","DOI":"10.1016\/j.eclinm.2024.102744","volume":"74","author":"L Weng","year":"2024","unstructured":"Weng L, Wei L, Zhang Q, Sun T, Kuang X, Huang Q, Cao Y, Liu X, Wang Q, Guo Y, et al. Safety and efficacy of allogenic human amniotic epithelial cells transplantation via ovarian artery in patients with premature ovarian failure: a single-arm, phase 1 clinical trial. EClinicalMedicine. 2024;74:102744.","journal-title":"EClinicalMedicine"},{"issue":"5","key":"4881_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/scrt335","volume":"4","author":"F Wang","year":"2013","unstructured":"Wang F, Wang L, Yao X, Lai D, Guo L. Human amniotic epithelial cells can differentiate into granulosa cells and restore folliculogenesis in a mouse model of chemotherapy-induced premature ovarian failure. Stem Cell Res Ther. 2013;4(5):124.","journal-title":"Stem Cell Res Ther"},{"key":"4881_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12014-020-09279-6","volume":"17","author":"X Fu","year":"2020","unstructured":"Fu X, Xu B, Jiang J, Du X, Yu X, Yan Y, Li S, Inglis BM, Ma H, Wang H, et al. Effects of cryopreservation and long-term culture on biological characteristics and proteomic profiles of human umbilical cord-derived mesenchymal stem cells. Clin Proteom. 2020;17:15.","journal-title":"Clin Proteom"},{"issue":"1","key":"4881_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13287-015-0148-4","volume":"6","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Xu M, Yao X, Li T, Wang Q, Lai D. Human amniotic epithelial cells inhibit granulosa cell apoptosis induced by chemotherapy and restore the fertility. Stem Cell Res Ther. 2015;6(1):152.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"4881_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/abbs\/gmz065","volume":"51","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Huang Y, Sun J, Gu T, Shao X, Lai D. Immunomodulatory effect of human amniotic epithelial cells on restoration of ovarian function in mice with autoimmune ovarian disease. Acta Biochim Biophys Sin (Shanghai). 2019;51(8):845\u201355.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"4881_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13287-021-02280-2","volume":"12","author":"Y Huang","year":"2021","unstructured":"Huang Y, Ma Z, Kuang X, Zhang Q, Li H, Lai D. Sodium alginate-bioglass-encapsulated hAECs restore ovarian function in premature ovarian failure by stimulating angiogenic factor secretion. Stem Cell Res Ther. 2021;12(1):223.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"4881_CR24","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1007\/s43032-021-00499-1","volume":"28","author":"T Deng","year":"2021","unstructured":"Deng T, He J, Yao Q, Wu L, Xue L, Wu M, Wu D, Li C, Li Y. Human umbilical cord mesenchymal stem cells improve ovarian function in chemotherapy-induced premature ovarian failure mice through inhibiting apoptosis and inflammation via a paracrine mechanism. Reprod Sci. 2021;28(6):1718\u201332.","journal-title":"Reprod Sci"},{"issue":"4","key":"4881_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.15283\/ijsc23045","volume":"16","author":"S Hong","year":"2023","unstructured":"Hong S, Lee DS, Bae GW, Jeon J, Kim HK, Rhee S, Jung KO. In vivo stem cell imaging principles and applications. Int J Stem Cells. 2023;16(4):363\u201375.","journal-title":"Int J Stem Cells"},{"issue":"1","key":"4881_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12929-021-00725-7","volume":"28","author":"WZ Zhuang","year":"2021","unstructured":"Zhuang WZ, Lin YH, Su LJ, Wu MS, Jeng HY, Chang HC, Huang YH, Ling TY. Mesenchymal stem\/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci. 2021;28(1):28.","journal-title":"J Biomed Sci"},{"issue":"6","key":"4881_CR27","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s12015-024-10745-z","volume":"20","author":"X Ye","year":"2024","unstructured":"Ye X, Lin Y, Ying Y, Shen X, Ni F, Wang F, Chen J, Zhao W, Yu X, Zhang D, et al. Human amniotic epithelial stem cells alleviate autoimmune premature ovarian insufficiency in mice by targeting granulosa cells via AKT\/ERK pathways. Stem Cell Rev Rep. 2024;20(6):1618\u201335.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"4881_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"S Keshtkar","year":"2018","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9(1):63.","journal-title":"Stem Cell Res Ther"},{"key":"4881_CR29","doi-asserted-by":"publisher","first-page":"665645","DOI":"10.3389\/fendo.2021.665645","volume":"12","author":"Z Liao","year":"2021","unstructured":"Liao Z, Liu C, Wang L, Sui C, Zhang H. Therapeutic role of mesenchymal stem cell-derived extracellular vesicles in female reproductive diseases. Front Endocrinol (Lausanne). 2021;12:665645.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4881_CR30","doi-asserted-by":"publisher","first-page":"28061","DOI":"10.1038\/s41598-024-79063-1","volume":"14","author":"Z Ge","year":"2024","unstructured":"Ge Z, Qiu C, Zhou J, Yang Z, Jiang T, Yuan W, Yu L, Li J. Proteomic analysis of human wharton\u2019s jelly mesenchymal stem\/stromal cells and human amniotic epithelial stem cells: a comparison of therapeutic potential. Sci Rep. 2024;14(1):28061.","journal-title":"Sci Rep"},{"issue":"8","key":"4881_CR31","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.62347\/CIUT6327","volume":"16","author":"L Xu","year":"2024","unstructured":"Xu L, Shi J, Wu S. Positron emission tomography probes for stem cell monitoring: a review. Am J Transl Res. 2024;16(8):3534\u201344.","journal-title":"Am J Transl Res"},{"key":"4881_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.reprotox.2021.12.003","volume":"107","author":"ZH Zhao","year":"2022","unstructured":"Zhao ZH, Wang XY, Schatten H, Sun QY. Single cell RNA sequencing techniques and applications in research of ovary development and related diseases. Reprod Toxicol. 2022;107:97\u2013103.","journal-title":"Reprod Toxicol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04881-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04881-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04881-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:13:25Z","timestamp":1770038005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04881-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4881"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04881-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human placenta and umbilical cord tissue collection was approved by the Institutional Ethics Committee of the International Peace Maternal and Child Health Hospital, and written informed consent was obtained from all donors prior to tissue collection (Approval title: SPECT\/MRI composite nanofluorescence probe for tracking and repairing mechanism of stem cells in premature ovarian failure, Approval number: GKLW 2020-34, Approval data: 2020-09-01). All animal experiments was approved by the Institutional Animal Care and Use Committees of the International Peace Maternal and Child Health Hospital (Approval title: SPECT\/MRI composite nanofluorescence probe for tracking and repairing mechanism of stem cells in premature ovarian failure, Approval number: GKLW 2020-34, Approval data: 2020-09-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}